![]() |
市場調查報告書
商品編碼
1916514
全球滅菌設備市場:市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的考量因素以及未來預測(2026-2034)Sterilization Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
預計2025年全球滅菌設備市場規模將達77.2億美元,2026年將成長至80.1億美元,到2034年將達到115.6億美元,在預測期(2026-2034年)內,複合年增長率(CAGR)為4.70%。市場成長的主要驅動因素是醫院獲得性感染 (HAI) 的日益增多、對有效感染控制的需求不斷增長以及製藥和生物技術研究活動的不斷擴大。
滅菌設備廣泛應用於醫院、專科診所、製藥廠、研究機構和生物製藥公司,用於消毒醫療器械、耗材和實驗室產品。正確的滅菌在預防診斷和手術過程中因受污染的醫療器械引起的感染方面發揮著至關重要的作用。
醫院感染的增加推動了市場需求
醫院感染,例如泌尿道感染 (UTI)、手術部位感染和敗血症,仍然是全球病患安全面臨的重大威脅。根據世界衛生組織 (WHO) 2022 年 5 月發布的數據,高收入國家每 100 名住院患者中就有 7 人,中低收入國家每 100 名住院患者中就有 15 人會在住院期間感染院內感染。令人擔憂的是,每 10 名確診院內感染的患者中就有 1 人死亡,凸顯了有效消毒技術的迫切性。
如此高的感染率和死亡率顯著增加了對先進消毒系統的需求,例如環氧乙烷 (EO) 消毒器、過氧化氫消毒器和高壓蒸氣滅菌器。全球醫療機構對感染預防方案日益重視,這持續推動市場擴張。
市場規模與區域趨勢
到 2025 年,北美將主導消毒設備市場,佔 48.56% 的市場佔有率,區域市場價值達 37.5 億美元。這一主導地位歸功於高昂的醫療保健支出、完善的醫院基礎設施以及旨在減少醫院獲得性感染 (HAI) 的嚴格監管準則。預計到 2026 年,美國市場規模將達到 36.7 億美元,這得益於全國 6,100 多家醫院的支持。
歐洲將在 2024 年佔據較大佔有率,並有望保持穩定成長,這得益於人們對感染控制和監管要求的認識不斷提高。德國、英國和法國等國家正積極升級其醫院消毒基礎設施。
亞太市場預計將以顯著的複合年增長率成長,這主要得益於醫療保健基礎設施的擴張、對藥物研發投入的增加以及人們對傳染病認識的提高。中國、印度和日本是主要貢獻者,預計到 2026 年,日本的市場規模將達到 20.3 億美元。
市場區隔洞察
按產品類型劃分,化學/氣體滅菌器預計將佔據市場主導地位,到 2026 年將佔據約 72.84% 的市場佔有率。此細分市場的主導地位歸功於低溫滅菌技術的廣泛應用,這種技術非常適合對熱敏感的醫療器材和聚合物。環氧乙烷和過氧化氫滅菌器廣泛應用於醫院和醫療器材生產場所。
由於熱力滅菌器(包括高壓滅菌器)在實驗室和研究機構中廣泛用於玻璃器皿和實驗室設備的滅菌,預計其市場佔有率也將增長。
按最終用戶劃分,醫院和專科診所佔據市場主導地位,預計到 2026 年將佔市場佔有率的 61.36%。手術量大和感染風險增加是推動該領域需求成長的主要因素。同時,在生物製品以及細胞和基因療法不斷發展的推動下,製藥和醫療器材製造領域預計將以 10.3% 的複合年增長率高速成長。
技術進步與產業趨勢
市場正擴大採用先進的滅菌技術,例如臭氧滅菌、汽化過氧化氫 (VHP) 滅菌和機器人輔助滅菌系統。自動化和自主消毒機器人的應用正在不斷擴展,以提高效率、精準度和安全性。
STERIS、Getinge AB、3M、ASP 和 Andersen Sterilizers 等領先企業正透過收購和技術創新持續拓展其產品組合。其中,STERIS 於 2023 年收購 BD 滅菌產品線,Getinge AB 於 2023 年收購 Ultra Clean Systems Inc. 以加強其在北美的市場地位,都是重要的發展動態。
The global sterilization equipment market was valued at USD 7.72 billion in 2025 and is projected to grow to USD 8.01 billion in 2026, reaching USD 11.56 billion by 2034, registering a compound annual growth rate (CAGR) of 4.70% during the forecast period (2026-2034). The market growth is primarily driven by the rising prevalence of hospital-acquired infections (HAIs), increasing demand for effective infection control, and expanding pharmaceutical and biotechnology research activities.
Sterilization equipment is widely used for decontaminating medical instruments, consumables, and laboratory products in hospitals, specialty clinics, pharmaceutical manufacturing facilities, research institutes, and biopharmaceutical companies. Proper sterilization plays a critical role in preventing infections caused by contaminated medical devices during diagnostic and surgical procedures.
Rising Burden of Hospital-Acquired Infections Driving Market Demand
Hospital-acquired infections such as urinary tract infections (UTIs), surgical site infections, and sepsis continue to pose a major threat to patient safety worldwide. According to World Health Organization (WHO) data published in May 2022, 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries acquire HAIs during hospital stays. Alarmingly, 1 in 10 patients diagnosed with HAIs dies, highlighting the urgent need for effective sterilization practices.
Such high infection and mortality rates have significantly increased demand for advanced sterilization systems, including ethylene oxide (EO) sterilizers, hydrogen peroxide sterilizers, and autoclaves. The growing emphasis on infection prevention protocols across healthcare facilities globally continues to support market expansion.
Market Size & Regional Performance
In 2025, North America dominated the sterilization equipment market, accounting for a 48.56% market share, with a regional market value of USD 3.75 billion. The dominance is attributed to high healthcare expenditure, a strong hospital infrastructure, and strict regulatory guidelines aimed at reducing HAIs. The U.S. market is estimated to reach USD 3.67 billion in 2026, supported by over 6,100 hospitals nationwide.
Europe held a substantial share in 2024 and is expected to maintain steady growth due to rising awareness of infection control and regulatory mandates. Countries such as Germany, the U.K., and France are actively upgrading hospital sterilization infrastructure.
The Asia Pacific market is anticipated to grow at a significant CAGR, driven by expanding healthcare infrastructure, increased pharmaceutical R&D investment, and rising awareness of infectious diseases. China, India, and Japan are key contributors, with Japan's market projected to reach USD 2.03 billion in 2026.
Market Segmentation Insights
By product type, chemical/gas sterilizers dominated the market, holding an estimated 72.84% market share in 2026. The segment's dominance is attributed to the widespread use of low-temperature sterilization technologies, which are ideal for heat-sensitive medical devices and polymers. Ethylene oxide and hydrogen peroxide sterilizers are extensively used in hospitals and medical device manufacturing.
Thermal sterilizers, including autoclaves, are also witnessing growth due to their extensive use in laboratories and research institutes for sterilizing glassware and laboratory equipment.
By end user, the hospital & specialty clinic segment led the market and is expected to account for 61.36% of the market share in 2026. The high volume of surgical procedures and increasing infection risk drive demand in this segment. Meanwhile, the pharmaceutical and medical device manufacturers segment is projected to grow at a strong CAGR of 10.3%, supported by rising biologics and cell & gene therapy development.
Technological Advancements and Industry Developments
The market is witnessing increasing adoption of advanced sterilization technologies, such as ozone sterilization, vaporized hydrogen peroxide (VHP), and robotic-assisted sterilization systems. Automation and autonomous disinfection robots are being increasingly deployed to improve efficiency, accuracy, and safety.
Key players including STERIS, Getinge AB, 3M, ASP, and Andersen Sterilizers continue to expand their product portfolios through acquisitions and technological innovation. Notable developments include STERIS' acquisition of BD's sterilization product lines in 2023 and Getinge AB's acquisition of Ultra Clean Systems Inc. in 2023 to strengthen its North American presence.
Conclusion
The global sterilization equipment market is set to witness steady and sustained growth through 2034, driven primarily by the rising burden of hospital-acquired infections, stricter infection prevention regulations, and expanding pharmaceutical and biotechnology research activities. With hospitals and specialty clinics remaining the largest end users, demand for reliable, low-temperature, and high-throughput sterilization systems will continue to rise, particularly for heat-sensitive medical devices and complex surgical instruments. North America will retain market leadership due to advanced healthcare infrastructure and stringent regulatory compliance, while Asia Pacific will emerge as the fastest-growing region supported by healthcare expansion, rising medical device manufacturing, and increased R&D investments. Technological advancements such as vaporized hydrogen peroxide systems, ozone sterilization, and robotic-assisted automation are further enhancing efficiency and safety, making sterilization processes more consistent and scalable. Overall, continuous innovation, regulatory pressure, and growing awareness of patient safety will remain key factors shaping long-term market expansion.
Segmentation By Product Type
By End-user
By Region